• Sourcing Solutions
  • Services & Membership
  • Help & Community
Business Type: Manufacturer
Location: Maryland, United States
Main Products: rh-IFN-Alpha2a,rh-GM-CSF,rh-G-CSF,rh-lysozyme,Protein PEGylation
Total Employees: 11 - 50 People
Total Annual Revenue: US$1 Million - US$2.5 Million
Year Established: 1996
Top 3 Markets: North America 11.11% South America 11.11% Eastern Europe 11.11%
MJ Biotech, Inc. manufactures and supplies active pharmaceutical ingredients (APIs) & intermedi...
MJ Biotech, Inc. manufactures and supplies active pharmaceutical ingredients (APIs) & intermediates, biologics, functional ingredients, herbal products, and finished drugs. MJ Biotech has herbal plantations, R& D labs and cGMP facilities engaging in natural product manufacture, organic synthesis, process development, biological fermentation and purification.
MJ Biotech has developed several FDA approved cGMP API manufacturing facilities, made a series of APIs & intermediates, and finished drugs. We supply the generic pharmaceutical industry and distributors with reliable sources of high quality APIs & intermediates at competitive prices.
MJ Biotech not only supplies high quality products, but also provides technical and regulatory supports to pharmaceutical industry. We work closely with our clients to facilitate them in product development and obtain approval from regulatory authorities worldwide.
Our mission is to serve the global pharmaceutical industry. Our strategy is to work together with the pharmaceutical manufacturers and distributors world wide for mutual success.

Trade Capacity View More >

Trade & Market
Main Markets Total Revenue(%)
North America 11.11%
South America 11.11%
Eastern Europe 11.11%
Southeast Asia 11.11%
Africa 11.11%
Oceania 11.11%
Mid East 11.11%
Eastern Asia 11.11%
Western Europe 11.11%
Export Percentage: 51% - 60%
Email to this supplier